Categories: Press Release

Cannabis Inhaler Market Future Trends and Scope Analysis Report

The Bone Growth Stimulator Market Size is valued at 1161.47 Million in 2023 and is predicted to reach 1967.46 Million by the year 2031 at a 7.04 % CAGR during the forecast period for 2024-2031.

 

Request for Freee Sample Pages: https://www.insightaceanalytic.com/request-sample/1417

 

Latest Drivers Restraint and Opportunities Market Snapshot:

Key factors influencing the global Cannabis Inhaler market are:

  • Clinical Research and Development
  • Medical Legalization and Acceptance
  • Increasing Demand for Smoke-Free Alternatives

The following are the primary obstacles to the Cannabis Inhaler market’s expansion:

  • Regulatory Challenges and Compliances
  • Healthcare Provider Knowledge & Reduced Public Faith
  • Limited Availability of Medical Cannabis

Future expansion opportunities for the global Cannabis Inhaler market include:

  • Market Expansion for Medical Cannabis
  • Innovative Inhaler Technologies

 

Market Analysis:

The increasing legalization of medical and recreational cannabis, growing acceptance of cannabis as a therapeutic agent, and advancements in inhaler technology are boosting this market with a focus on precise dosing, consistent effects, and smoke-free consumption. Cannabis inhalers offer a promising alternative for patients seeking symptom relief and wellness solutions. This is a reason for the significant growth of the Cannabis Inhaler market; as companies innovate to meet consumer demands, healthcare providers become more knowledgeable about cannabis therapeutics.

 

List of Prominent Players in the Cannabis Inhaler Market:

  • CBD Luxe
  • Fairwinds Cannabis,
  • Hand T press part manufacturing LTD.
  • Koi CBD
  • MUV
  • Vectura Group plc.

 

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1417

 

Recent Developments:

  • In November 2022, Grenco Science announced the launch of G Pen Hyer, a cannabis vaporizer designed to operate with both marijuana concentrates and dried cannabis flowers. The company constantly strives to improve its product offerings in the global landscape.
  • In November 2022, PAX Labs, Inc. announced the launch of the new line-up of PAX Mini and PAX Plus, its dry herb vaporizer devices, and the new PAX Infused Flower with a solvent-less hash for the ultimate all-natural, full-flower cannabis experience. The new products are likely to assist the company in gathering more customers and thus increase its profit margins.

 

Cannabis Inhaler Market Dynamics:

Market Drivers: Increasing Demand for Smoke-Free Alternatives

As consumers have become more health-conscious and seek smoke-free alternatives to traditional methods of cannabis consumption, like smoking, there is an increasing demand for cannabis inhalers. These Inhalers provide a convenient way to consume cannabis without any harmful effects related to smoking. This only encourages the growth of the cannabis Inhaler sector globally. Furthermore, consumers prefer to devour cannabis through an inhaler instead of smoking since it evades cigarette chemicals, carcinogens, and respiratory irritants. This aspect raises the market’s desire for cannabis Inhalers even more.

Challenges: Healthcare Provider Knowledge & Reduced Public Faith

Despite many advantages, some limiting constraints are projected to hamper global market expansion over the forecast period. One of the key factors contributing to the global market’s slowing growth is the need for more knowledge among healthcare providers. Besides, there was a supply of phony medication during the COVID-19 outbreak, which reduced the public’s faith in Cannabis Inhalers. Furthermore, a lack of knowledge among healthcare providers, including physicians and pharmacists, may act as a barrier to prescribing and recommending cannabis inhalers to patients. The lack of medical education in cannabis therapeutics can result in reluctance among healthcare professionals to incorporate cannabis-based treatments.

North America Is Expected To Grow With the Highest CAGR during the Forecast Period

The North American Cannabis Inhaler Market will likely register a significant revenue share and develop at a quick CAGR shortly. This is due to an increase in focus on adopting safer alternatives to cigarettes, which has helped to boost the cannabis inhaler market demand in North America. The usage of e-cigarettes, or vaporizers, is more prevalent among Americans under 30 years of age. It is as common among these young people as the usage of conventional cigarettes. Furthermore, the U.S. has allowed the controlled use of cannabis for medical and recreational purposes. This is an important step in legalizing cannabis and will boost demand for cannabis inhalers in this region.  

 


Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1443

 

Segmentation of Cannabis Inhaler Market-

By Type-

  • Cannabigerol (CBG)
  • Tetrahydrocannabivarinic (THCV)
  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)

By Application-

  • Sleep Disorders
  • Stress & Anxiety
  • Chronic Pain Management
  • Asthma
  • Others

By End-User-

  • Hospitals
  • Retail Pharmacies
  • Specialized Health Centers

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

 

Details insights on this market: https://www.insightaceanalytic.com/report/global-bone-growth-stimulator-market/1443

 

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Tags: , , , , , , , ,

See Campaign: https://www.insightaceanalytic.com/report/global-bone-growth-stimulator-market/1443

Contact Information:

Email: info@insightaceanalytic.com North America: +1 551 226 6109 Asia: +91 79 72967118 InsightAce

Tags:
iCN Internal Distribution, Go Media, IPS, Research Newswire, English